REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/05/2025
Voltar para busca
Dado oficial do USPTO
COLOSTAT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
COLOSTAT
ST13
US500000079220096Classe
5, 10, 44
Pedido
79220096
Registro
6044427
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
53
Atualização mais recente
06/05/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 44
Data de depósito
20/09/2017
Data de registro
05/05/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/05/2020
Última transação
06/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
81
Localização do titular
MELBOURNE VIC 3000, AU
Examinador
BRADLEY, EVELYN
Unidade examinadora
L40
Localização atual
POST REGISTRATION
Titulares e representantes
Titulares
Vision Tech Bio Pty Ltd
Representantes
CHARLES G ZUG NELSON MULLINS RILEY & SCARBOROUGH LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Biochemical preparations for medical and pharmaceutical usespecifically for cancer or neoplasia; biochemical diagnostic preparations for medical purposes; chemical diagnostic reagents for medical use; chemical diagnostic preparations for medical use ; diagnostic agents for pharmaceutical use being medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical use sold in kit form; diagnostic preparations for medical purposes; diagnostic reagents for medical use; diagnostic reagents for medical use sold in kit form; diagnostic substances for medical use; medical diagnostic test strips for cancer or neoplasia detection; cartridges sold prefilled with diagnostic agents for cancer or neoplasia detection; reagents for use in diagnostic tests for medical purposes; reagents for analytical purposes for medical purposes; reagents for medical use; diagnostic reagents for medical purposes; none of the foregoing being in the nature of pharmaceuticals
Classe 10
Apparatus for carrying-out diagnostic tests for medical purposesimmunoassay apparatusmolecular apparatusisoelectric focussing apparatusSDS/PAGE apparatusflow cytometry apparatusmass spectrometry apparatusMALDI-TOF apparatusbiosensor technology apparatusevanescent fibre optic apparatus and fluorescence resonance energy transfer apparatus all for the detection of cancer or neoplasia; apparatus for diagnostic purposesmedical diagnostic apparatus for detecting cancer or neoplasia; apparatus for medical diagnostic purposesimmunoassay apparatusmolecular apparatusisoelectric focussing apparatusSDS/PAGE apparatusflow cytometry apparatusmass spectrometry apparatusMALDI-TOF apparatusbiosensor technology apparatusevanescent fibre optic apparatus and fluorescence resonance energy transfer apparatus for medical diagnostic use all for the detection of cancer or neoplasia; apparatus sold in kit form for medical diagnostic purposesdiagnostic kits consisting primarily of probesbuffers and reagents for use in testing bodily fluids and bodily biological materials including bloodtissue and stool; diagnostic apparatus for medical purposesdiagnostic kits consisting primarily of probesbuffers and reagents for use in liquid or tissue biopsy testing; diagnostic test kits for the detection of haemoglobin in faeces; medical apparatus for diagnostic purposes for the detection of cancer or neoplasia; medical diagnostic apparatus sold in kit formdiagnostic kits consisting primarily of probesbuffers and reagents for use in testing bodily fluids and bodily biological materialsincluding bloodtissue and stool; medical diagnostic testing apparatusmedical diagnostic testing apparatus for bodily fluids and bodily biological materialsincluding bloodtissue and stool; medical electronic diagnostic apparatusmedical electronic diagnostic apparatus for testing bodily fluids and bodily biological materials including bloodtissue and stool; scientific apparatus for medical diagnostic purposes for testing bodily fluids and bodily biological materials including bloodtissue and stool; tools for medical diagnosticsimmunoassay apparatusmolecular apparatusisoelectric focussing apparatusSDS/PAGE apparatusflow cytometry apparatusmass spectrometry apparatusMALDI-TOF apparatusbiosensor technology apparatusevanescent fibre optic apparatus and fluorescence resonance energy transfer apparatus for testing bodily fluids and bodily biological materials including bloodtissue and stool; medical apparatus instrumentsimmunoassay apparatusmolecular apparatusisoelectric focussing apparatusSDS/PAGE apparatusflow cytometry apparatusmass spectrometry apparatusMALDI-TOF apparatusbiosensor technology apparatusevanescent fibre optic apparatus and fluorescence resonance energy transfer apparatus for testing bodily fluids and bodily biological materials including bloodtissue and stool; in vitro diagnostic testing apparatus for medical use for the detection of cancer or neoplasia
Classe 44
Medical testing and analysis for diagnostic purposes; surgical diagnostic services; providing medical information; medical services; medical treatment and medical diagnostic testing services; genetic testing services for medical purposes; medical screening services; health screening services in the field of cancer and neoplasia; medical advisory services relating to disease including providing disease risk assessment and related information
Publicações
Histórico de despachos e eventos da marca no USPTO.
53 publicações encontradas
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
26/04/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/12/2021
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
12/04/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
11/04/2021
PLGL
ASSIGNED TO PARALEGAL
11/04/2021
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
28/02/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/10/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/09/2020
FIMP
FINAL DISPOSITION PROCESSED
11/09/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/08/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2020
TMBN
TTAB RELEASE CASE TO TRADEMARKS
01/04/2020
OP.T
OPPOSITION TERMINATED NO. 999999
01/04/2020
OP.D
OPPOSITION DISMISSED NO. 999999
01/04/2020
RFNP
REFUSAL PROCESSED BY IB
10/05/2019
OP.I
OPPOSITION INSTITUTED NO. 999999
24/04/2019
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
19/04/2019
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
17/04/2019
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
17/04/2019
OPPF
OPPOSITION PAPERS RECEIVED AT TTAB
16/04/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/04/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/04/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/03/2019
PUBO
PUBLISHED FOR OPPOSITION
19/03/2019
GPNX
NOTIFICATION PROCESSED BY IB
15/03/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/02/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/02/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/02/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
14/02/2019
ALIE
ASSIGNED TO LIE
11/02/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/01/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
23/01/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
23/01/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
23/01/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
23/01/2019
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
07/12/2018
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/11/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/08/2018
GNFR
FINAL REFUSAL E-MAILED
04/08/2018
CNFR
FINAL REFUSAL WRITTEN
04/08/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/06/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/06/2018
RFNT
REFUSAL PROCESSED BY IB
03/02/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/01/2018
RFRR
REFUSAL PROCESSED BY MPU
13/01/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/12/2017
CNRT
NON-FINAL ACTION WRITTEN
29/12/2017
DOCK
ASSIGNED TO EXAMINER
25/12/2017
MAFR
APPLICATION FILING RECEIPT MAILED
11/11/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/11/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace COLOSTAT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.